Transgelin-2, a novel cancer stem cell-related biomarker, is a diagnostic and therapeutic target for biliary tract cancer
Article in BMC Cancer (March 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Identification of Serum Biomarkers to Monitor Therapeutic Response in Intestinal-Type Gastric Cancer
Article in International Journal of Molecular Sciences (March 2024)
An Integrated Analysis Identified TAGLN2 As an Oncogene Indicator Related to Prognosis and Immunity in Pan-Cancer
Article in Journal of Cancer (June 2023)